These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 32938249)
1. The predictive value of neutrophil-to-lymphocyte ratio for chronic obstructive pulmonary disease: a systematic review and meta-analysis. Guo R; Li J; Ma X; Pan L Expert Rev Respir Med; 2020 Sep; 14(9):929-936. PubMed ID: 32938249 [TBL] [Abstract][Full Text] [Related]
2. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients. Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858 [TBL] [Abstract][Full Text] [Related]
3. The Neutrophil to Lymphocyte Ratio Is Related to Disease Severity and Exacerbation in Patients with Chronic Obstructive Pulmonary Disease. Furutate R; Ishii T; Motegi T; Hattori K; Kusunoki Y; Gemma A; Kida K Intern Med; 2016; 55(3):223-9. PubMed ID: 26831014 [TBL] [Abstract][Full Text] [Related]
4. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker. Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of neutrophil-to-lymphocyte ratio for adverse outcomes in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A retrospective study. Vu-Hoai N; Ly-Phuc D; Duong-Minh N; Tran-Ngoc N; Nguyen-Dang K Medicine (Baltimore); 2024 Sep; 103(38):e39797. PubMed ID: 39312330 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study. Lee SJ; Lee HR; Lee TW; Ju S; Lim S; Go SI; You JW; Cho YJ; Lee GW; Jeong YY; Kim HC; Lee JD Korean J Intern Med; 2016 Sep; 31(5):891-8. PubMed ID: 27017385 [TBL] [Abstract][Full Text] [Related]
7. The prognostic values of neutrophil to lymphocyte ratio for outcomes in chronic obstructive pulmonary disease. Ye Z; Ai X; Liao Z; You C; Cheng Y Medicine (Baltimore); 2019 Jul; 98(28):e16371. PubMed ID: 31305434 [TBL] [Abstract][Full Text] [Related]
8. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review. Pascual-González Y; López-Sánchez M; Dorca J; Santos S Int J Chron Obstruct Pulmon Dis; 2018; 13():3651-3662. PubMed ID: 30464448 [TBL] [Abstract][Full Text] [Related]
9. The neutrophil-to-lymphocyte ratio as a marker of chronic obstructive pulmonary disease and its exacerbations: A systematic review and meta-analysis. Paliogiannis P; Fois AG; Sotgia S; Mangoni AA; Zinellu E; Pirina P; Carru C; Zinellu A Eur J Clin Invest; 2018 Aug; 48(8):e12984. PubMed ID: 29924383 [TBL] [Abstract][Full Text] [Related]
10. Relationship between neutrophil-lymphocyte ratio and short-term prognosis in the chronic obstructive pulmonary patients with acute exacerbation. Liu J; Liu J; Zou Y Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015366 [TBL] [Abstract][Full Text] [Related]
11. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD. Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients. El-Gazzar AG; Kamel MH; Elbahnasy OKM; El-Naggar ME Expert Rev Respir Med; 2020 Jan; 14(1):111-116. PubMed ID: 31577911 [No Abstract] [Full Text] [Related]
13. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Günay E; Sarınç Ulaşlı S; Akar O; Ahsen A; Günay S; Koyuncu T; Unlü M Inflammation; 2014 Apr; 37(2):374-80. PubMed ID: 24078279 [TBL] [Abstract][Full Text] [Related]
14. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Yao C; Liu X; Tang Z Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes. Aksoy E; Karakurt Z; Gungor S; Ocakli B; Ozmen İ; Yildirim E; Tuncay E; Agca MC; Ciftaslan Goksenoglu N; Adigüzel N Int J Chron Obstruct Pulmon Dis; 2018; 13():2721-2730. PubMed ID: 30233162 [TBL] [Abstract][Full Text] [Related]
16. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia. Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Feng X; Xiao H; Duan Y; Li Q; Ou X Int J Chron Obstruct Pulmon Dis; 2023; 18():1219-1230. PubMed ID: 37337582 [TBL] [Abstract][Full Text] [Related]
18. The role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease. Kurtipek E; Bekci TT; Kesli R; Sami SS; Terzi Y J Pak Med Assoc; 2015 Dec; 65(12):1283-7. PubMed ID: 26627508 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the relationship of neutrophil-to lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. Emami Ardestani M; Alavi-Naeini N Clin Respir J; 2021 Apr; 15(4):382-388. PubMed ID: 33210811 [TBL] [Abstract][Full Text] [Related]
20. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation? Çoban Ağca M; Aksoy E; Duman D; Özmen İ; Yıldırım E; Güngör S; Durmuş N; Aka Aktürk Ü; Saltürk C; Tepetam FM; Karakurt Z Tuberk Toraks; 2017 Dec; 65(4):282-290. PubMed ID: 29631526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]